- For researchers
- Facilities for research
- For the public
- Clinical trials
- Research partners
- Document library
- Working for us
Social media helping to recruit patients for research study
Type 1 diabetes is the most common severe chronic autoimmune disease worldwide and the incidence of the disease is rising rapidly. Type 1 diabetes causes the immune system to mistake cells in the pancreas as harmful and attack them.
This research study led by Dr Frank Waldron-Lynch is investigating a drug called aldesleukin (interleukin-2). The research team are investigating whether this medication can slow down or halt the damage to the pancreas of the people with newly diagnosed type 1 diabetes and if so, what dose of the drug is required for best results. The study team aims to recruit 40 patients over the course of two years who have been recently diagnosed with type 1 diabetes and have turned to Facebook and twitter to help spread the word and share news of the research study.
To find out more about what participation involves please contact a member of the team by email:
DILT1D@cimr.cam.ac.uk or telephone 01223 762327 or visit the website or Facebook and Twitter feeds for more information.